Ali Ataya M.D., MBA, ATSF

Dr. Ali Ataya is Professor of Medicine and Director of the Pulmonary Vascular Disease Center and Rare Lung Disease Program at the University of Florida in Gainesville. He is board-certified in Pulmonary, Critical Care, and Internal Medicine with clinical and research interests focused on pulmonary vascular diseases, and rare lung disorders including lymphangioleiomyomatosis (LAM), autoimmune pulmonary alveolar proteinosis (autoimmune PAP), and Hereditary Hemorrhagic Telangiectasia (HHT).

Dr. Ataya received his medical degree from the Royal College of Surgeons in Ireland (RCSI). He completed residency training in Internal Medicine at the Cleveland Clinic, followed by fellowship training in Pulmonary and Critical Care Medicine at the University of Florida, where he subsequently joined the faculty. Throughout his career, he has been involved in the development of multidisciplinary clinical programs and Centers of Excellence dedicated to the care of patients with rare and complex pulmonary diseases.

As a clinician-scientist, Dr. Ataya’s research focuses on the pathogenesis, diagnosis, and treatment of rare pulmonary diseases. He has served as Principal Investigator for numerous industry-sponsored and investigator-initiated clinical trials evaluating novel therapies for pulmonary vascular and rare lung diseases. His work has contributed to advancing the understanding of disease mechanisms, improving diagnostic approaches, and expanding therapeutic options for patients with uncommon respiratory conditions.

Dr. Ataya works closely with patient advocacy organizations and professional societies dedicated to pulmonary vascular disease and rare lung disorders. His career reflects a sustained commitment to advancing patient care through clinical innovation, collaborative research, medical education, and advocacy for patients living with rare and complex respiratory disorders.